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WHAT THIS PAPER ADDS
 This report outlines the initial use of a modiﬁed fenestrated stent graft for treating juxtarenal aortic aneurysms. The device
modiﬁcations might allow for a large proportion of juxtarenal aneurysms to be treated with a limited number of stent graft designs
creating a pathway towards off-the-shelf design.a r t i c l e i n f o
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Introduction: The use of EVAR for more complex aneurysm anatomy has become more widespread over
the past decade. Fenestrated and branched stent grafts for the visceral and iliac segment show promising
short- and midterm outcome and these procedures have become routine in many vascular centers.
However, at present, such grafts are customized to the individual patient and planning and
manufacturing leads to signiﬁcant treatment delay subjecting the patients to the risk of rupture during
the waiting period. The purpose of this report is to describe the ﬁrst experience in treating juxta/
suprarenal aneurysms using the ﬁrst version of a new fenestrated stent graft
Material and Methods: A fenestrated device was designed with two renal fenestrations, an SMA fenes-
tration and a scallop for the coeliac artery. The renal arteries were designed with an inner 6 mm
fenestration and an outer 15 mm diameter creating a dome to allow renal artery catheterization for
a range of renal artery distribution. Seven patients with complex visceral artery anatomy were treated
with customized stent grafts containing these pivot renal fenestrations.
Results: Technical success was uniform with 100% target vessel catheterization and 0% 30-day mortality.
In one case, the graft was displaced slightly during delivery resulting in a renal artery stent occlusion at 2
months postoperatively.
Conclusions: The development of a modiﬁed fenestrated device has shown this to be feasible and it has
the potential to reduce the need for extensive preoperative graft customization and establishing a true
off the shelf platform for juxta- and suprarenal AAA.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Endovascular aneurysm repair (EVAR) is an established treat-
ment option for infrarenal aortic aneurysms. The results from
randomised trials show that EVAR is beneﬁcial compared to open
aneurysm repair with regards to short- andmidtermmorbidity and
mortality.1,2 However, many patients are not anatomically suitable
for EVAR mainly due to inadequate proximal landing and ﬁxation
zones.3 This becomes even more signiﬁcant in patients presenting46 40 33 80 97.
ch).
ciety for Vascular Surgery. Publishewith aneurysm rupture where the anatomy is generally more
adverse to EVAR.4 Despite this, infrarenal EVAR is offered to an
increasing number of patients who do not fulﬁl the anatomic
requirements, as it is perceived as less traumatic. Recent studies
raise serious concerns regarding themidterm outcome of infrarenal
EVAR when applying it to patients outside of morphologic
instruction for use (IFU) criteria.5 Aneurysm growth during
midterm follow-up is frequent in this group of patients.
The use of EVAR for more complex aneurysm anatomy has
become more widespread over the past decade. Fenestrated and
branched stent grafts (SGs) for the visceral segment showd by Elsevier Ltd. All rights reserved.
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become routine in many vascular centres.6,7 However, at present,
such grafts are customised to the individual patient, and planning
and manufacturing leads to signiﬁcant treatment delay subjecting
the patients to the risk of rupture during the waiting period. The
current technology is therefore not available in the acute setting.8
Alterations to fenestration as well as delivery system design
might theoretically allow more patients to be treated with a few
standard SG designs.
The purpose of this report is to describe the ﬁrst experience in
treating juxta/suprarenal aneurysms using the ﬁrst version of
a new fenestrated SG based on the current COOK Zenith Fenestrated
device containing fenestration and delivery system modiﬁcations.
Methods
The device
The platform used in this series is based on the Zenith Fenes-
trated Stent graft that has been described in detail previously.7 In
short, the system is composed of three modular components: one
proximal tubular SG baring the fenestrations, one bifurcated
component and one iliac extension limb. Fenestrations come in
three conﬁgurations: small (6/8  6 mm) without crossing stent
struts, large (8e12 mm diameter) and scallops (6e12 mm deep).
Fenestrations are reinforced with a nitinol ring and marked with
gold markers. The conﬁguration of fenestrations and their posi-
tioning in height and on the circumference is planned according to
individual patient anatomy based on preoperative computed
tomography (CT) measurements.
To remove the need for individual case planning and thus ach-
ieve a standard design of the fenestrated proximal component,
some device modiﬁcations have been introduced. In the current
series, due to regulatory concerns, all SGs were tailored to speciﬁc
patient anatomy and not produced in an off-the-shelf conﬁgura-
tion. This was to allow for testing of the fenestration as well as
delivery system modiﬁcations before continuing with use of
a standard off-the-shelf SG. The current device is not computer
tomographic angiography (CTA) marked and was delivered as
a custom-made option. All cases were approved by the Depart-
mental Review Committee.
Fenestration design and positioning
To accommodate variability between the renal fenestrations and
target vessel (TV) position, the renal fenestrations weremodiﬁed to
create a dome appearance (Fig. 1a) where the outer diameter is
15 mm and the inner diameter is 6 mm. These ‘pivot fenestrations’
have nitinol wire reinforcements in inner rings, outer rings and in
the dome itself. This conﬁguration theoretically allows for cathe-
terisation of renal arteries that fall within the outer 15 mm diam-
eter while keeping the inner 6 mm fenestration for mating stent
seal. In a bench model, catheterisation of an off-clock TV through
this dome fenestration allowed the mating stent to act as a pivot on
deployment, directing the inner fenestration and mating stent
towards the TV (Fig. 1b). This theoretically alleviates the strain on
the mating stent to SG junction that occurs if a mating stent is
placed through a standard fenestration into a TV that is off-
position. Based on the renal and superior mesenteric artery
(SMA) positions in approximately 350 patients (unpublished data),
it was calculated that nearly 80% of TVs could ﬁt into two fenes-
trated graft designs where the diameter of the fenestrations for the
renal arteries was 15 mm (Fig. 2). The position of the SMA fenes-
tration (8 mm diameter) was left constant at 12 0’clock and
approximately 10 mm from the bottom of the coeliac scallop.In the modiﬁed design, the renal fenestrations have been ﬁtted
with a preloaded wire to obviate the need for catheterisation of the
fenestrations during the procedure. In addition, the preloaded
wires run through the SG on the delivery side using a modiﬁed
delivery handle which can accommodate two 6 French introducers
alongside it. The original concept and design of preloaded fenes-
tration has been previously described and reported.9 In this original
design, a separate preloaded wire was used for each renal fenes-
tration. The wires were loaded through the fenestrations and into
the top cap. This design was abandoned due to concerns that these
wires could get trapped in the top cap and make delivery impos-
sible. In the modiﬁed design, a single 0.018-inch, 3.5-m-long pre-
loaded wire is used. This wire passes through the side port on the
delivery handle, through the main body of the graft, out through
one renal fenestration, across the graft, into the other renal fenes-
tration, through the main body of the graft and ﬁnally out through
the second side port on the delivery handle (Fig. 3). Two 6 French
sheaths can thus be loaded over the wire in each side port and
advanced into the renal fenestrations.
Top cap alteration
In the standard fenestrated SG, the bare top stent is held in a top
cap identical to that used in the Zenith Flex AAA Stent graft. After
SG delivery this cap is captured and retrieved with the pusher in
the delivery system. In the modiﬁed device, a ‘self-retrieving’ top
cap has been designed. By designing a tapered tip in reversed
fashion on the proximal portion of the cannula, the top cap is given
a tapered proﬁle upon deployment of the bare ﬁxation stent. The
cap can then be retrieved through the system without having to
pass the pusher across the fenestrated component of the SG as is
necessary with the current device. The design of the bare top stent
remains identical to that of the standard fenestrated SG.
Spiral constraining wire
To provide better stability and torqability of the graft after
sheath removal, the inner cannula of the graft was attached to the
posterior wall of the SG along its entire length. This also keeps the
cannula from possibly obstructing the sheaths for the renal arteries
as these are passed into position.
Constraining ties
To provide increased ability to reposition the graft upon
deployment, the SG incorporates double diameter reducing ties.
The standard fenestrated SG only includes single diameter reducing
ties.
Delivery sequence
The device is oriented and positioned outside the patient under
ﬂuoroscopy as per standard fenestrated endografting.
Two 6F Flexor sheaths (COOK Inc) are introduced over the pre-
loaded wire and positioned in the main delivery sheath. After
endograft positioning in the aorta, the delivery sheath is with-
drawn and the renal sheaths (Flexor 6F 90 cm, COOK Inc) are
positioned in the renal fenestrations. A 12 F sheath is placed
through the contralateral groin to accommodate for a diagnostic
catheter as well as an SMA sheath (7F Flexor sheath 90 cm long).
The SMA is then catheterised, the 7F sheath advanced and a mating
covered stent positioned within the sheath.
For the renal arteries, a second puncture is then made in the 6F
sheath. A 4 F Curly-Q catheter is then used with a glidewire to
catheterise the renal artery. After position is conﬁrmed, the
Figure 1. a Prototype of an off-the-shelf device with pivot fenestrations. The latter is seen as a dome with a catheter through the fenestration. Note the inner fenestrations, which
measures 6 mm, and the outer fenestration, measuring 15 mm. Anterior on the graft is a 8  8 mm reinforced fenestration for the superior mesenteric artery and cranial to this
a 12 mm deep scallop for the coeliac trunk. b In this bench model, the deployed mating covered stent directs the pivot fenestration caudally. c Intraoperative image after stent graft
deployment. Note that the left renal pivot fenestration has everted towards the renal artery (eight markers mark the inner 6 mm fenestration). On the right side, the pivot
fenestration has simply ﬂattened against the aortic wall.
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com or Rosen www.cookmedical.com) in the renal artery. This
procedure is repeated for the second renal artery. The preloaded
wire is then removed from the system so the 6F sheaths can be
advanced into the renal arteries. Within the sheaths, appropriate
mating covered stents are then positioned. The spiral constraining
wire, diameter reducing ties and proximal trigger wire are then
removed in sequence. The self-retaining top cap is then deployed.
Finally, the distal trigger wire of the device, which is attached to the
self-retrieving top cap, is removed positioning the top cap within
the main body of the graft.
The SMA mating SG is then deployed. A CODA balloon is used
over the SMAwire to mould the fenestrated sealing segment whilethe renal sheaths are still in place. The renal SGs are then deployed
and ﬂared. After selective angiograms are done to conﬁrm TV
patency and integrity, the renal sheaths and wires are removed
allowing the removal of the top cap.
The remainder of the procedure with placement of the distal
bifurcated component and iliac extensions is done in a standard
fashion.
Patients
From Janto May 2011, seven patients (four women, mean age 72
years (range 61e80)) were treated for juxta- and suprarenal aneu-
rysm at two major vascular centres with large EVAR experience.
Table 1
Patient co-morbidities.
n
Coronary heart disease 3
Hypertension 7
Smoking 7
COPD 2
Previous abdominal Surgery 4
Diabetes 0
Figure 2. Distribution of renal arteries in relationship to the superior mesenteric
artery in 350 patients undergoing elective fenestrated endografting. Image courtesy of
Stephan Haulon and Roy Greenberg (Cleveland Clinic Foundation, USA).
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an infrarenal neck and the aneurysm extended to the level of the
renal arteries in four (juxtarenal) and between the renal arteries and
SMA in three (suprarenal aneurysm). Preoperative creatinine was
median 80 mmol l1 (range 63e167mmol l1). Patient co-morbidities
are summarised in Table 1.Figure 3. Prototype device with renal pivot fenestration. Note the wire running
through the fenestration cranially and back into the graft. This is the preloaded wire
over which the renal sheaths are tracked.All patients were treated with fenestrated SGs with the device
modiﬁcations described above. Six out of seven devices had two
renal dome fenestrations, a strut-free 8-mm standard fenestration
for the SMA and a 12-mm-deep scallop for the coeliac artery. One
device had two renal dome fenestrations and a scallop for the SMA
(20 mm deep 10 mm wide). All procedures were completed with
a bifurcated distal SG and iliac limb extension as per standard
fenestrated endografting. In the current series, due to regulatory
concerns, all SGs were tailored to speciﬁc patient anatomy and not
produced in an off-the-shelf conﬁguration. This was to allow for
testing of the fenestration as well as delivery system modiﬁcations
before continuing with use of a standard off-the-shelf SG.
Results
All procedures were successful and the 30-daymortality was 0%.
Median pre-discharge creatinine was 88 mmol l1 (range
59e143 mmol l1) with no patient displaying an increase over 30%.
All fenestrations were catheterised successfully and mating stents
placed accordingly for a perioperative TV patency of 100%. The
mean operative time was 246 min (range 200e335 min) with
a mean ﬂuoro time of 69 min (29e100 min) yielding a mean
radiation exposure of 35 mGy (range 8e86 mGy). The mean
contrast dose was 39 g I (range 24e62.6 g I).
In 10/14 renal fenestrations, Atrium Advanta 6 22mm covered
stents (Atrium Europe, www.atriummed.com) were used as mating
stents. In four of the pivot fenestrations, the dome did not
completely evert during deployment and sheath advancement. This
resulted in a longer fenestration to renal artery bridging distance. In
these cases, 28-mm-long, covered stents (JoStentgraft medium,
www.abbott.com) were mounted on standard percutaneous
transluminal angioplasty (PTA) balloons to adequately bridge the
gap. Advanta 8e38 mm covered stents were used as mating stents
for the SMA.
In case number 6, there were difﬁculties removing the pre-
loaded wire after renal artery catheterisation. This patient has
a quite tortuous sealing zone in the juxtarenal aorta. Due to the
friction uponwire removal, the SG migrated distally approximately
1.5 cm despite applying signiﬁcant push on the delivery system.
The graft also rotated about 20 during this manoeuvre. This
resulted in the need of longer mating stents for the TV.
In case number 7, there were difﬁculties removing the top cap
after complete system deployment, as the delivery cannula was
lying very close to one side of the graft. Attempts to remove the
cannula and top cap resulted in catching of one of the proximal
struts of the uncovered stent. The issue was resolved by pushing on
the entire sheath delivery, thereby creating a bow in the cannula
making move away from its position. While applying this pushing
force, the top cap could be removed.
No patient went to the intensive care unit (ICU). One patient was
reoperated for femoral artery occlusion after fascial closure. This
resulted in leg ischaemia and need for lower limb fasciotomy that
resulted in a prolonged hospital stay (17 days). No patient displayed
a signiﬁcant rise in S-creatinine postoperatively.
Mean hospital stay was 8 (4e17 days) days.
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All patients had CTA at 1 month. No endoleaks were detected.
All TVs were patent at 1-month follow up (FU) (Fig. 4). No signiﬁ-
cant conﬁgurational changes of the bridging covered stents were
seen except in patient number 6 described above.
Pat # 2 presented at 2 months post op with chest and back pain.
CTA revealed a well-excluded AAAwith no signs of endoleak. Three
centimetres above the top of the suprarenal ﬁxation stent of the SG,
a localised dissection was seen in the descending thoracic aorta
over a distance of 2 cm. The patient was treated conservatively with
pain measurement and blood pressure control and symptoms dis-
appeared over the course of 3 days. CTA after 3 days and 1 month
showed unchanged appearance of the dissection as well as the
treated aneurysm.
Pat # 6 presented 2 months postoperatively with slight
abdominal pain and discomfort. Workup revealed an S-creatinine
of 130 mmol l1 compared to 63 mmol l1 immediately post-
operatively (56 mmol l1 preoperatively). CTA showed occlusion of
the left renal stent with no ﬂow in the left kidney that had
decreased in size signiﬁcantly since the preoperative scan. In
addition, slight compression of the SMA stent was seen. Under local
anaesthesia, both the SMA and right renal mating stents were
reinforced with additional balloon expandable stents (VisiPro,
www.ev3.net (8e27 mm in SMA and 7e27 mm in right renal
artery)). Recanalisation of the occluded left renal stent failed. The
creatinine stabilised at 120 mmol l1. On repeat CTA 6 weeks later,
both SMA and the right renal mating stent were patent. Creatinine
was 120 mmol l1 and patient was doing well.Discussion
Anderson and coworkers ﬁrst described EVAR for pararenal and
suprarenal aneurysm with fenestrated SGs in 1999.10 It has since
become a valid treatment option for complex aneurysms unsuitable
for standard infrarenal endografting due to the lack of adequate
infrarenal sealing zone. Over 5000 implants have been performed
around the world and the current COOK Zenith Fenestrated device
is CE marked in Europe and undergoing clinical trials to achieve
FDA approval in the US. The results from the published series showFigure 4. CTA 6 weeks postoperatively showing patent renal and SMA stents and an
excluded aneurysm.a 30-day mortality of 1e5.5% and a TV patency at 1 year of
95e97%.11
The current device has some drawbacks pertaining to planning
and manufacturing. Each SG has to be planned and customised to
each individual patient to ensure adequate positioning of the TV
fenestrations. In patients with favourable anatomy, the planning is
a fairly straightforward process where the position of the fenes-
trations with regard to the TVs is predictable. However, in patients
with more adverse anatomy the planning becomes more difﬁ-
cult.8,12 Angulations in the juxtarenal sealing zone makes the
prediction of how the graft will actually position intraoperatively
more difﬁcult. This is also true in patients where the iliac access is
tortuous. The rotational movement of the graft upon introduction
through the access vessels canmake the ﬁnal position in the sealing
region incorrect. In most cases, the SG can be manually rotated to
compensate for this, but in cases of extreme tortuosity and iliac
narrowing, the rotational ability of the graft can be quite difﬁcult.
The combination of sealing zone angulation and access difﬁculties
has an additive effect making fenestration placement even more
unpredictable. In these situations, the fenestration can end up ‘off-
clock’ which can lead to problems with TV catheterisation. The
incorporation of additional diameter reducing sutures along the
device has at times been used to increase the rotational ability
when such situations are predicted. In most cases, as the data from
the published literature show, TV catheterisation and mating stent
placement are successful even in these more difﬁcult situations.
Concerns exist, however, that these bridging stents are subjected to
additional stress and strain during follow-up when they are forced
to traverse the fenestration to TV in a slightly tangential fashion.13
No detailed analysis of this speciﬁc issue exists at this time.
Another aspect of the current device is the production time. The
manufacturing process of these individualised grafts is time and
labour consuming which lead to device delivery times of 6e8
weeks under normal circumstances. This makes the device
unavailable in the emergency setting for patients presenting with
symptomatic or ruptured aneurysms that lack infrarenal sealing
zones. In addition, many surgeons feel hesitant to subject patients
with large, asymptomatic aneurysm to a 6e8-week treatment
delay while waiting for an SG.
The concept of the preloaded fenestrated SG with pivot fenes-
trations is a step to overcome some of these issues.14 The conﬁgu-
ration of the renal dome fenestrations in combination with
a standard SMA fenestration theoretically allows 80% of TV to be
within reach of the dome fenestrations using only two standardised
conﬁgurations of the fenestrated cuff.15 Using a standard as
opposed to a customised design might also result in more offset
fenestration versus renal artery position perhaps subjecting mating
stents to higher stress and strain despite the dome design of the
fenestration perhaps causing long term TV occlusions. Future
studies of a true off-the-shelf design must study this closely. In the
current series, patients were treated with customised grafts using
pivot fenestrations since the anatomy in these patients (particularly
neck angulation) was seen as complex and the wider ‘reach’ of the
pivot fenestrations might be beneﬁcial. In addition, regulatory
issues prohibited us from using a standard ‘off-the-shelf’ design.
The dome of the fenestration gives themating stent extra space and
avoids them being crushed between the graft and the aortic wall
when the inner fenestration and TV are not in alignment, a situa-
tion more likely to occur in tortuous neck anatomy. If there is space
between the graft and the aortic wall, the dome fenestration will
actually evert during mating stent placement creating a directional
cuff towards the renal artery. In this series where grafts were
planned with fenestrations in alignment, the inner fenestration in
most cases simply ﬂattened against the aortic wall. On a few
occasions, the dome fenestration remained inverted necessitating
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inner portions of the renal mating stents can come very close to
each other. Although this was not an issue in the cases performed, it
must be taken into consideration particularly when using the
device in narrow sealing zones.
Other features of the modiﬁed graft have also been added to
simplify the procedure. The addition of a spiral wire wrapping the
delivery cannula to the posterior aspect of the SG provides addi-
tional rotational ability to the system once it is unsheathed. In
addition, it also positions the cannula away from the fenestrations
themselves so it does not interfere with cannulation of the fenes-
trations and TV. We have noted the increased rotational ability to
be very useful in the cases performed.
The fact that the renal fenestrations have a preloaded wire
running alongside the main delivery system also offers several
advantages. First, it obviates the use of a large sheath in the
contralateral femoral artery during the TV catheterisation phase of
the procedure. Instead, an 8e12 F sheath is placed in the contra-
lateral groin to allow catheterisation of the SMA fenestration. This
allows continuous ﬂow to the contralateral lower limb for the
majority of the procedure as well as ﬂow in the contralateral
internal iliac artery that can provide some collateral ﬂow to the
ipsilateral lower limb where the femoral artery is largely occluded
by the main delivery sheath. This is an important aspect, particu-
larly during long procedures, where reperfusion injury with
compartment syndrome can be a problem after ﬂow is restored at
the end of the case.16
The fourth feature of the preloaded system is the through-and-
through preloaded fenestration wire. Apart from making cathe-
terisation of the renal fenestrations themselves unnecessary,
potentially making these procedures shorter, they also provide
another feature. By pulling on both ends of this wire during TV
catheterisation, the top end of the graft is effectively collapsed
creating extra space between the graft and the aortic wall. This
makes additional rotation and positioning of the graft easier if
needed and also alleviates TV catheterisation particularly if the
renal arteries are offset to the fenestrations. Indeed, this feature has
proved to be very useful in a number of cases where we have
implanted standard fenestrated grafts that have only had the pre-
loaded wire without the pivot fenestrations themselves. In one of
the cases in the current series, there was some difﬁculty removing
the preloaded wire that resulted in graft displacement. The
anatomy in this case was quite challenging with a signiﬁcantly
angulated sealing zone thatmight have contributed to this incident.
This obviously raises concerns, and further testing and reﬁnement
of the device is needed to determine the root cause of this and
avoiding it in the future.
Several manufacturers are in the process of developing fenes-
trated devices for juxtarenal aneurysms based on their corre-
sponding infrarenal SG platform. Both the Anaconda (Vascutec) and
Endologix (Ventana) SGs have been used, and reports of the ﬁrst
human implants have been reported at vascular conferences. The
exact conﬁguration of these devices, the level of customisation
required and the degree of standardisation possible are unknown.
The current design is based on the COOK Zenith Fenestrated plat-
form. There is now over 10 years of experiencewith this device, and
the short andmidterm outcomeswith regard to device delivery and
durability are excellent. Although the new device described has
some added features, the immediate implant success is good andhas the potential to simplify safe delivery of the graft. Additional FU
will determine the durability of the new pivot fenestrations as well
as TV patency.
In conclusion, the development of a modiﬁed fenestrated device
has shown this to be feasible and it has the potential to reduce the
need for extensive preoperative graft customisation making and
establishing a true off-the-shelf platform for juxta- and suprarenal
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